Patents by Inventor Thomas L. Andresen

Thomas L. Andresen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REVERSIBLE LINKERS AND USE THEREOF
    Publication number: 20230248841
    Abstract: Disclosed herein are compositions and methods for preparation and delivery of protein therapeutics, and more particularly reversible linkers and use thereof.
    Type: Application
    Filed: November 11, 2022
    Publication date: August 10, 2023
    Inventor: Thomas L. Andresen
  • THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20230233609
    Abstract: Disclosed herein are compositions and methods for preparation and use of protein therapeutics, and more particularly protein clusters or backpacks having a plurality of therapeutic protein monomers reversibly crossed-linked by biodegradable linkers.
    Type: Application
    Filed: November 7, 2022
    Publication date: July 27, 2023
    Inventor: Thomas L. Andresen
  • Reversible linkers and use thereof
    Patent number: 11547760
    Abstract: Disclosed herein are compositions and methods for preparation and delivery of protein therapeutics, and more particularly reversible linkers and use thereof.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: January 10, 2023
    Assignee: Torque Therapeutics, Inc.
    Inventor: Thomas L. Andresen
  • Therapeutic protein compositions and methods of making and using the same
    Patent number: 11524033
    Abstract: Disclosed herein are compositions and methods for preparation and use of protein therapeutics, and more particularly protein clusters or backpacks having a plurality of therapeutic protein monomers reversibly crossed-linked by biodegradable linkers.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: December 13, 2022
    Assignee: Torque Therapeutics, Inc.
    Inventor: Thomas L. Andresen
  • T cells surface-loaded with immunostimulatory fusion molecules and uses thereof
    Patent number: 11471490
    Abstract: Immunostimulatory fusion molecules that include an immune cell targeting moiety and a cytokine molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: October 18, 2022
    Assignee: Torque Therapeutics, Inc.
    Inventors: Thomas L. Andresen, De-Kuan Chang, Douglas S. Jones, Jesse Lyons, Jonathan D. Nardozzi, Ulrik B. Nielsen, Michael Feldhaus
  • Reversible Linkers and Use Thereof
    Publication number: 20210154313
    Abstract: Disclosed herein are compositions and methods for preparation and delivery of protein therapeutics, and more particularly reversible linkers and use thereof.
    Type: Application
    Filed: September 5, 2018
    Publication date: May 27, 2021
    Inventor: Thomas L. ANDRESEN
  • Therapeutic Protein Compositions and Methods of Making and Using the Same
    Publication number: 20210060065
    Abstract: Disclosed herein are compositions and methods for preparation and use of protein therapeutics, and more particularly protein clusters or backpacks having a plurality of therapeutic protein monomers reversibly crossed-linked by biodegradable linkers.
    Type: Application
    Filed: September 5, 2018
    Publication date: March 4, 2021
    Inventor: Thomas L. Andresen
  • Immunostimulatory Fusion Molecules and Uses Thereof
    Publication number: 20200330514
    Abstract: Immunostimulatory fusion molecules that include an immune cell targeting moiety and a cytokine molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.
    Type: Application
    Filed: July 3, 2018
    Publication date: October 22, 2020
    Inventors: Thomas L. Andresen, De-Kuan Chang, Douglas S. Jones, Jesse Lyons, Jonathan D. Nardozzi, Ulrik B. Nielsen
  • Polynucleotides Encoding Immunostimulatory Fusion Molecules and Uses Thereof
    Publication number: 20200306301
    Abstract: Polynucleotides encoding immunostimulatory fusion molecules that include an immune cell targeting moiety and a cytokine molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.
    Type: Application
    Filed: July 3, 2018
    Publication date: October 1, 2020
    Inventors: Thomas L. Andresen, Douglas S. Jones